| 臺大學術典藏 |
2018-09-10T03:32:08Z |
Metaplastic carcinoma of the breast-analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer
|
Kuo, S.-H.; Chen, C.-L.; Huang, C.-S.; Cheng, A.-L.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2018-09-10T03:32:08Z |
Ultrasound-guided mammotome biopsy of breast lesions in Taiwanese women
|
Lin, J.-H. and Guo, W.-H. and Huang, C.-S. and Chang, K.-J. and Shih, J.-C. and Hsieh, F.-J.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2018-09-10T03:32:08Z |
Utility assessment for different clinical phases of breast cancer in Taiwan
|
CHIUN-SHENG HUANG; CHIE, WEI-CHU; HUANG, CHIUN-SHENG; CHEN, JEN-HAU; CHANG, KING-JEN; Chie, W.-C. and Huang, C.-S. and Chen, J.-H. and Chang, K.-J.; CHIE, WEI-CHU;HUANG, CHIUN-SHENG;CHEN, JEN-HAU;CHANG, KING-JEN; 季瑋珠;黃俊升;陳人豪;張金堅 |
| 臺大學術典藏 |
2018-09-10T03:32:08Z |
Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: An implication for mutator phenotype and breast cancer pathogenesis
|
CHIUN-SHENG HUANG; Shen, C.-Y. and Yu, J.-C. and Lo, Y.-L. and Kuo, C.-H. and Yue, C.-T. and Jou, Y.-S. and Huang, C.-S. and Lung, J.-C. and Wu, C.-W. |
| 臺大學術典藏 |
2018 |
Use of dual mTOR inhibitor MLN0128 against everolimus-resistant breast cancer
|
Chen S.; CHIUN-SHENG HUANG; Cui Y.X.; Somlo G.; Kanaya N.; Lo C.; Nguyen D.; Petrossian K.;Nguyen D.;Lo C.;Kanaya N.;Somlo G.;Cui Y.X.;Chiun-Sheng Huang;Chen S.; Petrossian K. |
| 臺大學術典藏 |
2018 |
Effect of glucocorticoid use on survival in patients with stage I–III breast cancer
|
Lin C.-H.;Chuang P.-Y.;You S.-L.;Chiang C.-J.;Chiun-Sheng Huang;Wang M.-Y.;Chao M.;Lu Y.-S.;Cheng A.-L.;Tang C.-H.; Chuang P.-Y.; You S.-L.; Chiang C.-J.; CHIUN-SHENG HUANG; Wang M.-Y.; Chao M.; Lu Y.-S.; Cheng A.-L.; Tang C.-H.; Lin C.-H. |
| 臺大學術典藏 |
2018 |
ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer
|
Kruper L.; Yuan Y.; Somlo G.; Mortimer J.; Chen S.; Petrossian K.; Kanaya N.; Lo C.; Hsu P.-Y.; Nguyen D.; Yang L.; Yang L.; Warden C.; Wu X.; Pillai R.; Bernal L.; CHIUN-SHENG HUANG; Petrossian K.;Kanaya N.;Lo C.;Hsu P.-Y.;Nguyen D.;Yang L.;Yang L.;Warden C.;Wu X.;Pillai R.;Bernal L.;Chiun-Sheng Huang;Kruper L.;Yuan Y.;Somlo G.;Mortimer J.;Chen S. |
| 臺大學術典藏 |
2018 |
Computer-Aided tumor diagnosis in 3-D breast elastography
|
Huang Y.-S.;Takada E.;Konno S.;Chiun-Sheng Huang;Kuo M.-H.;Chang R.-F.; Huang Y.-S.; Takada E.; Konno S.; CHIUN-SHENG HUANG; Kuo M.-H.; Chang R.-F. |
| 臺大學術典藏 |
2018 |
Reply to 'the St Gallen international expert consensus on the primary therapy of early breast cancer 2017: Te point of view of an international panel of experts in radiation oncology' by Kirova et al.
|
on behalf of the Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017; Xu B.; Whelan T.J.; Bonnefoi H.; Brucker S.Y.; Cardoso F.; Carey L.; Ciruelos E.; Cuzick J.; Denkert C.; Di Leo A.; Ejlertsen B.; Francis P.; Galimberti V.; Garber J.; Gulluoglu B.; Goodwin P.; Harbeck N.; Hayes D.F.; CHIUN-SHENG HUANG; Huober J.; Khaled H.; Jassem J.; Jiang Z.; Karlsson P.; Morrow M.; Orecchia R.; Osborne K.C.; Pagani O.; Partridge A.H.; Pritchard K.; Ro J.; Rutgers E.J.T.; Sedlmayer F.; Semiglazov V.; Shao Z.; Smith I.; Toi M.; Tutt A.; Viale G.; Watanabe T.; Bergh J.; Baselga J.; Thrlimann B.; Andr? F.; Senn H.-J.; Piccart-Gebhart M.; Regan M.M.; Colleoni M.; Loibl S.; Gnant M.; Winer E.P.; Burstein H.J.; Curigliano G.; Dubsky P.; Dubsky P.;Curigliano G.;Burstein H.J.;Winer E.P.;Gnant M.;Loibl S.;Colleoni M.;Regan M.M.;Piccart-Gebhart M.;Senn H.-J.;Thrlimann B.;Andr? F.;Baselga J.;Bergh J.;Bonnefoi H.;Brucker S.Y.;Cardoso F.;Carey L.;Ciruelos E.;Cuzick J.;Denkert C.;Di Leo A.;Ejlertsen B.;Francis P.;Galimberti V.;Garber J.;Gulluoglu B.;Goodwin P.;Harbeck N.;Hayes D.F.;Chiun-Sheng Huang;Huober J.;Khaled H.;Jassem J.;Jiang Z.;Karlsson P.;Morrow M.;Orecchia R.;Osborne K.C.;Pagani O.;Partridge A.H.;Pritchard K.;Ro J.;Rutgers E.J.T.;Sedlmayer F.;Semiglazov V.;Shao Z.;Smith I.;Toi M.;Tutt A.;Viale G.;Watanabe T.;Whelan T.J.;Xu B.;On Behalf Of The Panel Members Of The St Gallen International Expert Consensus On The Primary Therapy Of Early Breast Cancer 2017 |
| 臺大學術典藏 |
2017 |
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
|
Ataseven, B.; Verrill, M.; De Laurentiis, M.; Jung, K.H.; Azim, H.A.; Al-Sakaff, N.; Lauer, S.; Shing, M.; Pivot, X.; Koroveshi, D.; Bouzid, K.; Casalnuovo, M.; Cascallar, D.; Korbenfeld, E.P.; Bastick, P.; Beith, J.; Colosimo, M.; Friedl; er, M.; Ganju, V.; Green, M.; Patterson, K.; Redfern, A.; Richardson, G.; Ceric, T.; Gordana, K.; Beato, C.A.; Ferrari, M.; Hegg, R.; Helena, V.; Ismael, G.F.; Lessa, A.E.; Mano, M.; Morelle, A.; Nogueira, J.A.; Timcheva, K.; Tomova, A.; Tsakova, M.; Zlatareva-Petrova, A.; Asselah, J.; Assi, H.; Brezden-Masley, C.; Chia, S.; Freedman, O.; Harb, M.; Joy, A.A.; Kulkarni, S.; Prady, C.; Gaete, A.A.A.; Matamala, L.; Torres, R.; Yanez, E.; Franco, S.; Urrego, M.; Gugi?, D.; Vrbanec, D.; Melichar, B.; Prausov; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2017 |
Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients
|
Chow, L.W.C. and Biganzoli, L. and Leo, A.D. and Kuroi, K. and Han, H.S. and Patel, J. and Huang, C.S. and Lu, Y.S. and Zhu, L. and Chow, C.Y.C. and Loo, W.T.Y. and Gl\\uck, S. and Toi, M.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2017 |
A longitudinal study of diurnal cortisol patterns and associated factors in breast cancer patients from the transition stage of the end of active cancer treatment to post-treatment survivorship
|
Hsiao F.-H.;Jow G.-M.;Kuo W.-H.;Wang M.-Y.;Chang K.-J.;Lai Y.-M.;Chen Y.-T.;Chiun-Sheng Huang; Hsiao F.-H.; Jow G.-M.; Kuo W.-H.; Wang M.-Y.; Chang K.-J.; Lai Y.-M.; Chen Y.-T.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2017 |
Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients
|
Toi M.; Gl?ck S.; Loo W.T.Y.; Chow C.Y.C.; Zhu L.; Lu Y.S.; CHIUN-SHENG HUANG; Patel J.; Chow L.W.C.;Biganzoli L.;Leo A.D.;Kuroi K.;Han H.S.;Patel J.;Chiun-Sheng Huang;Lu Y.S.;Zhu L.;Chow C.Y.C.;Loo W.T.Y.;Gl?Ck S.;Toi M.; Chow L.W.C.; Biganzoli L.; Leo A.D.; Kuroi K.; Han H.S. |
| 臺大學術典藏 |
2017 |
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
|
Kim S.-B.;Maslyar D.J.;Dent R.;Im S.-A.;Espi? M.;Blau S.;Tan A.R.;Isakoff S.J.;Oliveira M.;Saura C.;Wongchenko M.J.;Kapp A.V.;Chan W.Y.;Singel S.M.;Baselga J.;Kim S.-B.;Lee K.S.;Im S.-A.;Espi? M.;Wang H.-C.;Blau S.;Dent R.;Tan A.;Sohn J.H.;De Laurentiis M.;Estevez L.G.;Chiun-Sheng Huang;Romieu G.;Velez M.;Villanueva R.;Conte P.F.;Dakhil S.;Debled M.;Martin A.G.;Hurvitz S.;Kim J.H.;Levy C.;Oliveira M.;Rovira P.S.;Seo J.H.;Valero V.;Vidal G.;Wong A.;Allison M.A.K.;Figlin R.;Chan D.;Chen S.-C.;Chen Y.-H.;Cobleigh M.;De Braud F.;Dirix L.;Hansen V.;Bessard A.H.;Iannotti N.;Isakoff S.;Lawler W.;Monta?O A.;Salkini M.;Seigel L.;On Behalf Of The, Lotus Investigators, Lotus Investigators; Estevez L.G.; De Laurentiis M.; Sohn J.H.; Wang H.-C.; Blau S.; Dent R.; Tan A.; Espi? M.; Im S.-A.; Lee K.S.; Kim S.-B.; Baselga J.; Kim S.-B.; Maslyar D.J.; Dent R.; Im S.-A.; Espi? M.; Blau S.; Tan A.R.; Isakoff S.J.; Oliveira M.; Saura C.; Wongchenko M.J.; Kapp A.V.; Chan W.Y.; Singel S.M.; Allison M.A.K.; Vidal G.; Wong A.; Valero V.; Seo J.H.; CHIUN-SHENG HUANG; Romieu G.; Velez M.; Villanueva R.; Conte P.F.; Dakhil S.; Debled M.; Martin A.G.; Hurvitz S.; Kim J.H.; Levy C.; Oliveira M.; Rovira P.S.; on behalf of the, LOTUS investigators, LOTUS investigators; Seigel L.; Salkini M.; Monta?o A.; Figlin R.; Chan D.; Chen S.-C.; Chen Y.-H.; Cobleigh M.; De Braud F.; Dirix L.; Hansen V.; Bessard A.H.; Iannotti N.; Isakoff S.; Lawler W. |
| 臺大學術典藏 |
2017 |
Computer-aided prediction of axillary lymph node status in breast cancer using tumor surrounding tissue features in ultrasound images
|
Moon W.K.;Lee Y.-W.;Huang Y.-S.;Lee S.H.;Bae M.S.;Yi A.;Chiun-Sheng Huang;Chang R.-F.; Moon W.K.; Lee Y.-W.; Huang Y.-S.; Lee S.H.; Bae M.S.; Yi A.; CHIUN-SHENG HUANG; Chang R.-F. |
| 臺大學術典藏 |
2017 |
Automatic Marker-free Longitudinal Infrared Image Registration by Shape Context Based Matching and Competitive Winner-guided Optimal Corresponding
|
CHIUN-SHENG HUANG; Chang Y.-C.; Lai J.-H.; Wang H.-J.; Lee C.-Y.; Lee C.-Y.;Wang H.-J.;Lai J.-H.;Chang Y.-C.;Chiun-Sheng Huang |
| 臺大學術典藏 |
2016 |
MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast
|
Jeng Y.-M.; Yang Y.-W.; CHIUN-SHENG HUANG; Lien H.-C.; Lien H.-C.;Chiun-Sheng Huang;Yang Y.-W.;Jeng Y.-M. |
| 臺大學術典藏 |
2016 |
Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: Implications for pathogenesis and histogenesis
|
Lien H.-C.; CHIUN-SHENG HUANG; Yang Y.-W.; Jeng Y.-M. |
| 臺大學術典藏 |
2016 |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
|
Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; Yu S.-L.; Chang K.-J.; Chen P.-L.; Ni Y.-H.; CHIUN-SHENG HUANG; Li H.-Y.; Yeh M.-H.; Liu C.-Y.; Cheng F.T.-F.; Kuo S.-H.; Wang M.-Y.; Lin C.-H.; Lu Y.-S.; Huang A.-C.; Kuo W.-H.; Lin P.-H. |
| 臺大學術典藏 |
2016 |
Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI
|
Lo C.-M.; Chen J.-H.; CHIUN-SHENG HUANG; Chang Y.-C.; Chen H.-H.; Chang R.-F. |
| 臺大學術典藏 |
2016 |
Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial
|
Piccart-Gebhart M.; Holmes E.; Baselga J.; De Azambuja E.; Dueck A.C.; Viale G.; Zujewski J.A.; Goldhirsch A.; Armour A.; Pritchard K.I.; McCullough A.E.; Dolci S.; McFadden E.; Holmes A.P.; Tonghua L.; Im Y.-H.; CHIUN-SHENG HUANG; D?eras V.; Hillman D.W.; Wolff A.C.; Jackisch C.; Lang I.; Untch M.; Smith I.; Boyle F.; Xu B.; Gomez H.; Suter T.; Gelber R.D.; Perez E.A.; Eidtmann H.; Dinh P.; Di Cosimo S.; Harbeck N.; Tjulandin S. |
| 臺大學術典藏 |
2016 |
Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer
|
Cheng A.-L.; Lin C.-H.; Shen C.-Y.; Hsueh T.-H.; Wu P.-F.; Kuo K.-T.; Wang M.-Y.; Kuo W.-H.; Chen I.-C.; Chang Y.-C.; Lu Y.-S.; Chung K.-P.; CHIUN-SHENG HUANG; Lu T.-P. |
| 臺大學術典藏 |
2016 |
Should pertuzumab be used as part of neoadjuvant treatment prior to the release of the APHINITY trial results?
|
CHIUN-SHENG HUANG; Chen T.W.-W.; Lin C.-H. |
| 臺大學術典藏 |
2015 |
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays
|
Cheng A.-L.; Lu Y.-S.; Chen W.-W.; Lin C.-H.; Chen I.-C.; CHIUN-SHENG HUANG; Hu F.-C.; Kuo W.-H.; Kuo K.-T.; Wang C.-C.; Wu P.-F.; Chang D.-Y.; Wang M.-Y.; Chang C.-H. |
| 臺大學術典藏 |
2015 |
Personalization of loco-regional care for primary breast cancer patients (part 2)
|
Klimberg V.S.; Noh D.Y.; Krop I.E.; Han W.; Noguchi S.; Pegram M.D.; Yamauchi H.; Lee E.-S.; Larionov A.A.; Bevilacqua J.L.; Yoshimura M.; Sugie T.; Yamauchi A.; CHIUN-SHENG HUANG; Ho A.Y.; Yamauchi C.; Chow L.W.; Kunkler I.; Sasano H.; Benson J.R.; Winer E.P.; Toi M.; Toi M.;Winer E.P.;Benson J.R.;Inamoto T.;Forbes J.F.;Von Minckwitz G.;Robertson J.F.;Grobmyer S.R.;Jatoi I.;Sasano H.;Kunkler I.;Ho A.Y.;Yamauchi C.;Chow L.W.;Chiun-Sheng Huang;Han W.;Noguchi S.;Pegram M.D.;Yamauchi H.;Lee E.-S.;Larionov A.A.;Bevilacqua J.L.;Yoshimura M.;Sugie T.;Yamauchi A.;Krop I.E.;Noh D.Y.;Klimberg V.S.; Jatoi I.; Grobmyer S.R.; Robertson J.F.; Von Minckwitz G.; Inamoto T.; Forbes J.F. |
